This site uses cookies to store information on your computer. Learn more x

DSM reports Q2 2015 results

Commenting on the results, Feike Sijbesma, CEO/Chairman of the DSM Managing Board, said: “I am pleased to report good progress in Q2 with a solid volume growth in Nutrition and a step-up in Performance Materials. The priority of improving our operational performance is starting to deliver results. With increasingly challenging macro-economic conditions we remain focused on further improving the operational performance of DSM’s businesses while making continued progress in innovation and sustainability........ More>

Announcement of exchange ratio Interim dividend 2015

Koninklijke DSM N.V. announces that the exchange ratio of the interim dividend financial year 2015 in shares has been determined. This will amount to 1 new ordinary share for every 91.460 existing ordinary shares. Based on the average weighted price of 14 August up to and including 20 August 2015 of EUR 50.3032, 1/91.460 the share represents a value of EUR 0.55, which is virtually equal to the gross dividend in cash of EUR 0.55 per ordinary share. Both the cash dividend and stock dividend will be made payable to shareholders on 25 August 2015.
Dividend in the form of ordinary shares for the interim dividend financial year 2015 is  842,075 ordinary shares.

Share price and volume

Share price> € 0.0 0.0%

More share info >